HDR Brachytherapy Boost for Prostate Cancer: PCS VI Protocol


Objectives

At the end of this presentation, the participant will be able to:

  • Discuss the toxicity results of this protocol
  • Analyze the relationship between this protocol and ASCEND-RT

 

Evaluation for: HDR Brachytherapy boost for prostate cancer: PCS VI Protocol (Click Here)



  • 13:20 - 13:30
  • May 18, 2024